JBIO earnings: a negative outcome, -18.9%

On November 15, 2021, Jade Biosciences, Inc. reached its earnings. The result was a negative outcome, and the stock moved -18.9% in the window around the event. It had already run +52.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.